Schmoll D: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
|firstname=Dieter | |firstname=Dieter | ||
|title=Dr. | |title=Dr. | ||
|institution=Sanofi-Aventis Deutschland GmbH | |institution=Sanofi-Aventis Deutschland GmbH | ||
R&D | R&D DIAB Div. / Innovation&ext.Network. FF | ||
|address=Industriepark Hoechst | |address=Industriepark Hoechst | ||
| Line 12: | Line 12: | ||
|city=Frankfurt am Main | |city=Frankfurt am Main | ||
|country=Germany | |country=Germany | ||
|mailaddress= | |mailaddress=Dieter.Schmoll@sanofi.com | ||
|weblink=www.sanofi.de | |||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | |||
::::* [[IOC54|IOC54 Schroecken AT]] | |||
Latest revision as of 16:45, 12 February 2018
| Name | Schmoll Dieter, Dr. |
|---|---|
| Institution | Sanofi-Aventis Deutschland GmbH
R&D DIAB Div. / Innovation&ext.Network. FF |
| Address | Industriepark Hoechst
Bldg. H825, Room 243, 65926 |
| City | Frankfurt am Main |
| State/Province | |
| Country | Germany |
| [email protected] | |
| Weblink | www.sanofi.de |
| O2k-Network Lab | DE Frankfurt Schmoll D |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Karusheva 2019 Am J Clin Nutr | 2019 | Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M (2019) Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. Am J Clin Nutr 110:1098-107. |
